News

Signia Therapeutics to present at the 2nd i4iD – Immunotherapies for infectious Diseases – conference

November 21, 2018

Signia Therapeutics announces it has been selected to present its strategy based on clinical gene expression infection signatures to the upcoming 2nd edition of i4iD “Immunotherapies for Infectious Diseases – host-directed therapies”.

This conference is organized jointly by MabDesign, a French non-profit membership organization in the immunotherapy field, and BIOASTER, a technology institute that leads research programs in four major application fields in health-related microbiology and infectious diseases. The conference will take place in MATMUT Stadium, Lyon, France on December 10thand 11th, 2018.

Presentation will be delivered by Dr Philippe Personne, CEO of Signia Therapeutics, on Monday December 10thin the pitch session “Innovation on HDT Approaches To Treat Infectious Diseases”.

Visit the i4id website https://i4id.org/and Signia Therapeutics website https://signiatherapeutics.com/fr/for detailed information.

Leave a comment

Signia therapeutics.com - Copyright 2021. All right reserved.

signiatherapeutics.com — Website No Longer Available

This domain has expired and been acquired by SerpNames.com. We have restored an archived version of this website using materials from Archive.org to preserve its historical and SEO value.

This is not the active website of the former owner or organization. We are not affiliated with or endorsed by any prior operators or related entities that may still be active elsewhere.

All content displayed here was publicly available prior to expiration and is presented under fair use for informational and archival purposes only.

Our intention is solely to maintain the domain’s historical context and not to harm or misrepresent any business, organization, or individual. No logins, payments, or personal data are collected or processed on this page.

If you are the previous owner or wish to request content removal, please contact team@serpnames.com.